Medullary Thyroid Cancer
specificA neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and al
32
Centers
35
Active Trials
—
Cancer Funding
Top Centers for Medullary Thyroid Cancer(32)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 72.7 |
| 2 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 72.7 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 66.3 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 66.3 |
| 5 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 66.3 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 66.3 |
| 7 | University of Illinois Cancer CenterChicago, IL Active Research Program | 66.3 |
| 8 | Cancer Center at IllinoisUrbana, IL Active Research Program | 66.3 |
| 9 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 66.3 |
| 10 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 50.9 |
| 11 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 50.9 |
| 12 | NCI Comprehensive Active Research Program | 50.9 |
| 13 | NCI Comprehensive Active Research Program | 50.9 |
| 14 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 50.9 |
| 15 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 50.9 |
| 16 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 50.9 |
| 17 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 50.9 |
| 18 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.9 |
| 19 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 50.9 |
| 20 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 50.9 |
| 21 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 50.9 |
| 22 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 50.9 |
| 23 | BC CancerVancouver, BC Active Research Program | 50.9 |
| 24 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 50.9 |
| 25 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 34.7 |
| 26 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 34.7 |
| 27 | NCI Clinical | 34.7 |
| 28 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 34.7 |
| 29 | Cedars-Sinai CancerLos Angeles, CA | 34.7 |
| 30 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 34.7 |
| 31 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive | 34.7 |
| 32 | 34.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →